Review reviewHigh

CVE-2026-55849

CycloneDX cyclonedx-node-npm

@cyclonedx/cyclonedx-npm creates CycloneDX Software Bill of Materials from npm projects. From 2.1.0 before 5.0.0, the CLI passes user-supplied --workspace values to a subshell without proper sanitization when npm_execpath is unset or empty, allowing arbitrary OS command execution with the privileges of the invoking user. This issue is fixed in version 5.0.0.

CVSS
8.5
EPSS
0.16%
5.71% percentile
CISA KEV
Not listed
Published
2026.07.09
PRIORITY ASSESSMENT

Review review

The CVSS severity warrants an early asset and exposure review.

Known exploitationNot established by KEV
Exploit probability0.16%
Technical severityCVSS 8.5

Vulnerability overview

@cyclonedx/cyclonedx-npm creates CycloneDX Software Bill of Materials from npm projects. From 2.1.0 before 5.0.0, the CLI passes user-supplied --workspace values to a subshell without proper sanitization when npm_execpath is unset or empty, allowing arbitrary OS command execution with the privileges of the invoking user. This issue is fixed in version 5.0.0.

Affected product and versions

Product
CycloneDX cyclonedx-node-npm
Affected versions
>= 2.1.0, < 5.0.0
Fixed versions
No verified fixed-version field is available yet

Recommended response sequence

Confirm exposure before applying a vendor-supported change.

Full remediation guide
  1. 1
    Identify

    Confirm that CycloneDX cyclonedx-node-npm and an affected version are present.

  2. 2
    Prioritize

    Combine exploitation signals with asset exposure and business criticality.

  3. 3
    Remediate

    Follow the vendor advisory or supported update path and preserve rollback options.

  4. 4
    Verify

    Recheck the version, service health, access paths, and relevant logs.

Technical data

CVSS vector
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
CWE
CWE-78
CVE-2026-55849 — CycloneDX cyclonedx-node-npm | SECUFOCUS NOW